Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China · Delayed Price · Currency is CNY

9.58

-0.15 (-1.54%)

Sep 24, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
CDMO	1.03B	-	968.26M	1.08B	813.10M
Intersegment offset	-6.74B	-	-5.88B	-	-
Others	277.99M	-	448.25M	191.12M	191.89M
Preparations	7.70B	-	6.45B	3.21B	2.64B
Active Pharmaceutical Ingredient (API)	3.20B	-	3.44B	2.67B	2.72B
Total	5.48B	-	5.43B	7.16B	6.37B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	-	-	-	649.85M	557.63M
Foreign	-	-	-	6.51B	5.81B
Mainland China	393.95M	342.51M	397.84M	-	-
United States of America	1.34B	1.43B	1.28B	-	-
Europe	2.73B	2.37B	2.62B	-	-
Hong Kong	7.91M	7.20M	18.10M	-	-
Other Countries/Regions	995.55M	1.11B	1.12B	-	-
Total	5.46B	5.26B	5.43B	7.16B	6.37B